No Data
No Data
Wells Fargo Upgrades 3, Downgrades 2 Healthcare REITs on Price to Earnings Growth and Yield
Wells Fargo Upgrades Sabra Health Care REIT Inc(SBRA.US) to Buy Rating, Raises Target Price to $20
Wells Fargo Upgrades Sabra Health Care to Overweight From Equalweight, Adjusts Price Target to $20 From $16
Best Real Estate Growth Stocks as the Sector Is Seeing a Revival
Here Are the Most Attractive High-yield Dividend Stocks Right Now
Citi Upgrades Sabra Health Care REIT Inc(SBRA.US) to Buy Rating, Raises Target Price to $20
No Data
No Data